Acquistion of Respiratory Motion Inc (US) by Senzime AB (SE) – Amount not disclosed

Carnegie acted as sole financial adviser to Senzime in the acquistion of the US company Respiratory Motion Inc. Through the acquisition, Senzime expands its product portfolio within the market for monitoring of vital signs and extends the Company’s capability to capture a larger share of the patient journey outside of the operating room as well. Senzime develops and markets systems, driven by unique algorithms and sensors, to follow patients ’ nervous systems and electrical impulses – before, during and after surgery. The company’s solution is called TetraGraph, a medical technology system that digitally and continuously measures the degree of neuromuscular blockade in the patient.
July 2022.